QADR BIOTECHNOLOGY · THE SCIENCE

The evidence behind every formula.

Not wellness by intuition. Wellness by design — built on peer-reviewed research, clinical dosing standards, and sublingual delivery science.

THE SCIENCE

Why sublingual changes everything.

Chapter 1 — The Problem with Pills
Chapter 2 — The Sublingual Pathway
Chapter 3 — Clinical Dosing
Chapter 4 — QADR Methodology
Chapter 1 — The Problem with Pills

01 · THE PROBLEM WITH PILLS

Digestion destroys before delivering.

When you swallow a supplement, it travels through your stomach, small intestine, and liver before any active ingredient reaches your bloodstream. This process — known as first-pass metabolism — can degrade 50 to 80% of the active compound before it ever reaches systemic circulation. Higher dose on the label does not mean higher dose in your body.

Chapter 2 — The Sublingual Pathway

02 · THE SUBLINGUAL PATHWAY

A different route. A different result.

The sublingual mucosa — the thin membrane under the tongue — is richly vascularized. Compounds placed here cross directly into the bloodstream via capillary absorption, bypassing the gastrointestinal tract and liver entirely. This pathway has been documented in pharmacological literature for decades and is used in clinical contexts for precisely this reason: speed and bioavailability.

Chapter 3 — Clinical Dosing

03 · CLINICAL DOSING

The dose makes the difference.

Most supplement formulas are built around cost, not efficacy. Ingredients are listed on the label at doses too small to have meaningful physiological effect — a practice sometimes called "label decoration." Every Stryō formula is dosed to match or exceed the ranges used in peer-reviewed research demonstrating the ingredient's effect. If the evidence doesn't support the dose, the ingredient doesn't make the formula.

Chapter 4 — QADR Methodology

04 · QADR METHODOLOGY

Built by biotechnology, not by marketing.

QADR Biotechnology Holding operates at the intersection of formulation science and consumer wellness. Our approach begins with the literature — identifying ingredients with credible evidence, at effective doses, for specific physiological targets. Stryō is the consumer expression of this methodology: the same scientific discipline, accessible without a prescription.

PEER-REVIEWED EVIDENCE

The research we build on.

These are not claims. These are documented findings from published scientific literature.

Bhowmik D. et al. — The Pharma Innovation Journal, 2012

Sublingual drug delivery achieves significantly higher bioavailability by bypassing hepatic first-pass metabolism, enabling faster onset of action compared to conventional oral routes.

Read the study →

Narang N. & Sharma J. — International Journal of Pharmaceutical Sciences, 2011

The sublingual route provides rapid absorption through the highly permeable sublingual mucosa, with systemic availability that exceeds oral tablet delivery for many compounds.

Read the study →

Rathbone M.J. et al. — Drug Delivery, 2008

Sublingual administration enables therapeutic concentrations to be achieved rapidly, making it particularly suitable for actives where onset time and bioavailability are clinically relevant.

Read the study →

DOSING PHILOSOPHY

Doses that actually work.

Many supplements underdose. We don't.

Biotin 30–100 mcg 5,000 mcg
Ashwagandha (KSM-66) 100–300 mg 600 mg
CoQ10 30–100 mg 200 mg

Each dose reflects the ranges used in peer-reviewed studies demonstrating clinical effect. Not rounded down for cost. Not inflated for marketing.

QUALITY & SAFETY

Our non-negotiables.

— SOURCING

Verified supply chain.

We source exclusively from suppliers who can trace ingredients to their origin. Branded ingredients (KSM-66®, and others) come with third-party certifications. Generic anonymous raw materials do not meet our standard.

— TESTING

Third-party tested.

Every Stryō formula is tested by independent laboratories for purity, potency, and absence of contaminants. What the label says is what the capsule or strip contains — verified externally, not just declared.

— TRANSPARENCY

Full disclosure, always.

No proprietary blends. No undisclosed additives. Every ingredient, every dose, every other ingredient — fully listed. We believe transparency is not a marketing position. It is a minimum standard.

— COMPLIANCE

FDA structure-function compliance.

Every claim made across our products and communication has been reviewed for compliance with FDA structure-function guidelines. We describe what ingredients support — not what they treat. The line matters, and we stay on the right side of it.

QADR.

ABOUT QADR BIOTECHNOLOGY

The science company behind Stryō.

QADR Biotechnology Holding is a Moroccan-based life sciences holding incorporated to advance evidence-based approaches to human wellness. Our operating entities include Stryō (consumer wellness), GutRecover Therapeutics (therapeutic formulation research), and Microbiomae (microbiome science).

Stryō is the direct-to-consumer expression of QADR's formulation methodology — applying the same standards used in pharmaceutical-adjacent research to the supplements you take every day. The science behind Stryō is not marketing language. It is the operational baseline we hold ourselves to.

Learn our story →

FREQUENTLY ASKED

The questions we get most.

What does "sublingual" actually mean?

Sublingual means "under the tongue." It refers to a delivery method where a compound is placed beneath the tongue and absorbed through the sublingual mucosa — the thin, highly vascularized membrane in that area — directly into the bloodstream, bypassing the digestive system.

Is sublingual delivery proven to be more effective than swallowing a pill?

The sublingual route has been studied in pharmacological literature for decades. Research consistently demonstrates that sublingual delivery achieves higher bioavailability for many compounds compared to conventional oral routes, due to avoidance of hepatic first-pass metabolism. The degree of improvement varies by compound — which is why our formula selection considers which actives benefit most from this delivery pathway.

Are your ingredients safe to absorb sublingually?

Yes. Every ingredient in a Stryō strip has been selected for sublingual compatibility — meaning appropriate molecular weight, solubility, and mucosa tolerance. Our formulas are manufactured to GMP standards and tested for purity and potency by independent laboratories.

What is first-pass metabolism and why does it matter?

First-pass metabolism (or hepatic first-pass effect) refers to the process by which the liver breaks down substances absorbed from the gastrointestinal tract before they reach systemic circulation. For many active compounds, this significantly reduces the amount that ultimately reaches the bloodstream. Sublingual delivery bypasses this process by entering the bloodstream directly through the sublingual mucosa.

Why do you use "supports" and "helps" language instead of direct health claims?

These are FDA-regulated structure-function claims. Under FDA guidelines, dietary supplement manufacturers can describe how an ingredient supports a normal bodily function — but cannot claim to diagnose, treat, cure, or prevent diseases. Our language is chosen carefully to describe mechanisms of support accurately while remaining within these regulatory boundaries. For more detail, see our Health Disclaimer.

What is a proprietary blend and why don't you use them?

A proprietary blend lists multiple ingredients under a single combined weight, without disclosing individual doses. This practice makes it impossible for consumers to verify whether active ingredients are present at clinically meaningful levels. We do not use proprietary blends. Every ingredient and every dose is disclosed individually on our Supplement Facts panels.

Are your formulas tested by third parties?

Yes. Independent laboratory testing for potency, purity, and absence of contaminants is part of our quality protocol. We do not rely solely on manufacturer certificates of analysis — third-party verification is a standard, not an option.

How does QADR Biotechnology differ from a typical supplement company?

QADR operates as a life sciences holding with multiple entities, including one focused on therapeutic formulation research. Stryō is built on the same scientific discipline — evidence-based ingredient selection, clinical dosing ranges, and verified supply chains — applied to consumer wellness. The key difference is that our starting point is the scientific literature, not the retail shelf.

START

Science-backed wellness. Delivered smarter.